Dr. Judy Burnfield, vice president of research at Madonna announces its model system of post-COVID rehabilitation care, made possible through $7.5 million from public and private grants. The model system combines clinical programming, research, mental health services and education to address the long-term impact of COVID-19.
The COVID-19 pandemic might not be raging like it once was, but the virus is still having an impact on many Nebraskans, including one local 73-year-old.
Mary Schulte is still fighting against long COVID, where symptoms persist for many months following the onset of an infection.
“(Symptoms) come and go,” Schulte said. “The worst ones, of course, are the brain fog, the problem with concentration, word-finding difficulty … and horrible fatigue. That just never goes away.”
Schulte is far from alone in this battle — a June pulse survey from the Centers for Disease Control and Prevention estimated that 30% of Nebraskans who have had COVID-19 have had some form of long COVID.
Since February, Schulte has been at Madonna Rehabilitation Hospital's new model system of post-COVID rehabilitation care. The model system combines clinical programming, research, mental health services and education to address the long-term impacts of COVID-19.
Table of Contents
People are also reading…
“Our program is driven by helping to restore the minds, the bodies and the spirits of these individuals and helping them to get back to being able to do what they want to be able to do,” said Dr. Judith Burnfield, vice president of research at Madonna’s Institute for Rehabilitation Science and Engineering.
In January 2022, the $7.5 million model system was brought to the Lincoln campus through public and private grants. Burnfield said the money is being used not only for research and education of the program, but for technology to help their patients.

Long COVID patient Mary Schultz and occupational therapist Kristin LaPorta work through a vision therapy test at Madonna Rehabilitation Hospital on Wednesday.
Senaptec is one of the machines that is used to work on peripheral visions. During Schulte’s therapy session on Wednesday, she was instructed to sit down in front of the touchscreen and select icons as they appeared on the screens. Schulte’s therapy also included a Vectogram with polarized glasses to develop and strengthen simultaneous vision.
Before the pandemic, Schulte had never taken medicine or used a cane. She was first diagnosed with COVID-19 in 2020 and had severe symptoms.

Long COVID patient Mary Schultz and occupational therapist Kristin LaPorta work through a vision therapy test at Madonna Rehabilitation Hospital on Wednesday.
“The first time was horrible because it was that god-awful coughing that people described,” Schulte said.
A year later, she was diagnosed again with a more mild case, but one that left her with long-term symptoms. Her luck continued to go downhill as she was then diagnosed with breast cancer before having COVID-19 for a third time last year.
“It’s a year and a half, and I don’t see an end in sight,” Schulte said. “But, because of Madonna, I’ve seen improvement. I have made improvements and the goal is for me not to backslide.”
Jade Bertsch, a physical therapist, has been working with Schulte for six months.
“The things that she struggles with are very common for what other people are struggling with, too,” Bertsch said. “The progress isn’t fast, but it’s steady and she’s a very hard worker.”
Schulte is one of the nearly 1,000 individuals who have been rehabilitating from COVID-19 challenges at Madonna. For Schulte, her experience has given her hope for the future.
“I truly was floating down to an abyss before I came here,” Schulte said. “In many ways, they’ve saved me and brought me back.”
At Madonna, Schulte has been learning numerous ways to help improve her memory, brain fog and balance through language, cognitive and physical therapy.
“I can tell that there have been improvements, and it’s not just the physical improvements or the mental improvements,” Schulte said. “When I first started, I could no longer drive on the highway and I couldn’t figure out why. I thought I was losing my mind.”
That's a common theme among patients with long COVID, Burnfield said.
"They feel as though maybe they’re going crazy because nobody has been able to really pull together that picture of what’s happening for them,” Burnfield said. “To be able to understand and to learn and come to a place that knows long COVID and knows how to help that person rehabilitate has been a huge relief for many of these individuals.”
There are three key aspects to Madonna’s model system of care: clinical programming to address needs, community awareness and research.
“COVID is such a new disease, we don’t yet know as a country what are the best practices in being able to help people rehabilitate from long COVID,” Burnfield said. “One of the things that we’re doing is also starting to advance the science of understanding the impact of specific treatments."
Madonna also has an online self-assessment to help individuals identify symptoms that are consistent with long COVID. The questionnaire only takes a few minutes and can be found at therapyplus.madonna.org/programs/post-covid-rehabilitation-clinic.
After the form is completed, Burnfield said to print off the information to bring to a physician to help start the conversation. The current wait time is under a month from the time a referral is sent in to when individuals have their first visit.
As for Schulte, her therapy appointments are set to end this fall and she’s accepted that she will never truly be back to the way she was before having COVID-19.
“I know that there is not going to be a cure in my lifetime because of my age, and that’s OK,” Schulte said. “As long as there are improvements, and there have been improvements.”
For now, she’s focusing on the small victories and enjoying the simple things in life.
“I’m finally able to go back to reading,” Schulte said. “I used to read one book a week, and then COVID ripped that away.”
Schulte said she isn’t looking forward to ending her therapy at Madonna and she will miss the staff.
“I admire each and every one of them to do this kind of work because we are not the easiest people,” Schulte said. “Broken people are not the easiest people to fix and so I feel very fortunate.”
Eight long-haul symptoms of COVID-19
Eight long-haul symptoms of COVID-19

Most people who get infected with the coronavirus recover within a few weeks. However, some continue to experience symptoms weeks or even months after they are infected. They have what are known as long-haul symptoms of COVID-19. As such, they are sometimes called COVID-19 long-haulers. Sometimes, even patients who had a mild or asymptomatic coronavirus infection can become long-haulers.
Scientists want to learn more about who becomes a long-hauler and why. This knowledge can help shape public policy, and determine the best standards of care and precautions to prevent viral transmission of the disease.
An advocacy group called Patient-Led Research for COVID-19 released its first report in May 2020, to provide an in-depth look at the experiences of more than 600 COVID-19 long-haulers. Susannah Fox, who studies online communities of patients with chronic conditions, told MIT Technology Review in August 2020 that such patient groups will be more important to health professionals, particularly during crises such as the coronavirus, that cause health professionals to be overwhelmed.
“The future of health care and technology is being built on such communities,” Fox said. She added that some of the earliest users of online bulletin boards and other online communities were patients with chronic diseases.
Cognitive FX compiled a list of long-term COVID-19 symptoms based on research and data from experts at institutions across the world, including the Centers for Disease Control and Prevention, Mayo Clinic, Northwestern University, and New York-Presbyterian/Columbia University.
Altered sense of smell and taste

Among 100 people who presented to Northwestern Memorial Hospital’s Neuro-COVID-19 clinic in Chicago, with symptoms compatible with the Infectious Diseases Society of America COVID-19 guidelines, 59% reported dysgeusia, or an impaired sense of taste, and 55% reported anosmia, or an altered sense of smell. The patients were seen at the hospital, which operates in a partnership with Northwestern University’s Feinberg School of Medicine, an average of five to six months after the onset of COVID-19 symptoms. Dysgeusia and anosmia may be the result of viral invasion of the olfactory cortex, the part of the brain associated with the sense of smell and taste.
Difficulty breathing

Dyspnea, or difficulty breathing, is the most common long-haul symptom of COVID-19. More than 40% to almost 70% of patients with COVID-19 report having trouble breathing 60 to 100 days after diagnosis or hospitalization. Dyspnea has been linked to viral damage of the alveolar and epithelial cells in the lungs, and inflammatory damage to vascular cells. Researchers have found corticosteroids may help some long-haul COVID-19 patients with residual lung inflammation or persistent inflammatory interstitial lung disease.
Memory issues

Cognitive impairment after COVID-19 recovery can present as trouble with concentration, memory, understanding words and language, and/or executive function. These cognitive difficulties may be the result of damage to the hippocampus, the part of the brain that plays an important role in learning and memory. Damage to the hippocampus may put people with COVID-19 long-haul symptoms at risk for the hippocampal-related degeneration characteristic of Alzheimer’s disease.
More frequent blood clots

The coronavirus that causes COVID-19 can make blood cells more likely to coagulate, or clump and form clots. Specifically, heart damage caused by COVID-19 is likely the result of clots in the small vessels, or capillaries, in the heart. The risk of blood clots in those with long-haul COVID-19 may be associated with damage from severe inflammation, although scientists don’t know how long the inflammation can persist. Doctors might want to treat blood clots in those with long-haul COVID-19 with low-molecular weight heparin and direct oral anticoagulants versus vitamin K antagonists, because patients taking vitamin K antagonists need frequent blood tests to monitor medication levels.
Trouble sleeping

Patients with long-haul COVID-19 may develop or will continue to experience neuropsychiatric symptoms, including insomnia, or sleeplessness, for months after they are initially infected. These symptoms may be the result of nerve cell damage due to inflammation. Levels of immune system activation are directly associated with cognitive and behavioral changes. Although little compelling evidence exists that the coronavirus that causes COVID-19 infects neurons, autopsies have found evidence that the virus causes changes in the brain that promote inflammation in nerve cells and blood vessels in the brain. Inflammaging, the chronic low-level brain inflammation that develops with age, may also play a role in the persistent psychiatric effects of COVID-19.
Lightheadedness

Dizziness, sometimes called vertigo, has long been associated with viral infections. So researchers are not really surprised that studies from around the world have found vertigo is one of the most common symptoms of COVID-19. Scientists in Pakistan believe that the coronavirus enters the nervous system via the circulatory system, and binds to the angiotensin-converting enzyme 2 receptors in the lining of the capillaries in the brain. Hypoxia, or insufficient oxygen delivery, and damage caused by blood clots and inflammation are other possible ways nervous system damage can cause vertigo in those with long-haul COVID-19.
Strain after physical or mental work

Scientists do not know much about what causes post-COVID-19 fatigue, also called post-exertional malaise or chronic fatigue/myalgic encephalopathy, following viral infection. One possible explanation is that while the body fights off the coronavirus, the immune system releases proteins that promote inflammation and can stimulate the immune response. These proteins are called cytokines, and they are also responsible for the symptoms of post-COVID-19 fatigue. However, cytokine levels sometimes do not return to normal and cause ongoing symptoms.
Chest pain and heart palpitations

Viral infection, inflammation and the immune response, and a decrease in the number of, or downregulation of, angiotensin-converting enzyme 2 receptors may be the root cause of chest pain and heart palpitations in those with long-haul COVID-19. Infection, inflammation, and the downregulation of ACE2 receptors damage the heart muscle; the pericardium, or the sac around the heart; and the conduction system that controls the heartbeat by conducting electrical impulses through the heart. Scarring of the heart muscle can lead to palpitations, or arrhythmias, as can cytokines, which are proteins that stimulate the immune response and promote inflammation.
This story originally appeared on Cognitive FX and was produced and distributed in partnership with Stacker Studio.
Reach the writer at 402-473-7241 or [email protected]. On Twitter @ajohnson6170